A new study published in the journal of Anesthesiology Research and Practice showed that the cardioprotective advantages of epidural anesthesia (EA) may be mostly attributed to ...
Raised blood pressure remains the leading modifiable risk factor for cardiovascular disease and premature mortality worldwide ...
In this Q&A, Mineralys CEO Jon Congleton discusses how targeting aldosterone could reshape hypertension treatment. Aldosterone synthase inhibitors (ASIs) are drawing a lot of attention. What first ...
Current treatment options for primary aldosteronism are limited to surgery or mineralocorticoid receptor antagonists when surgery isn't an option. In a phase IIa trial, baxdrostat resolved or reduced ...
There we go. I'll be making forward-looking statements for the course of the day. So as I noted, Mineralys is focused on how do we target aldosterone in cardiorenal metabolic disorders. We do that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results